These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15378000)

  • 1. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer.
    Kawakubo H; Carey JL; Brachtel E; Gupta V; Green JE; Walden PD; Maheswaran S
    Oncogene; 2004 Oct; 23(50):8310-9. PubMed ID: 15378000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
    Kawakubo H; Brachtel E; Hayashida T; Yeo G; Kish J; Muzikansky A; Walden PD; Maheswaran S
    Cancer Res; 2006 Jul; 66(14):7075-82. PubMed ID: 16849553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
    Gupta V; Yeo G; Kawakubo H; Rangnekar V; Ramaswamy P; Hayashida T; MacLaughlin DT; Donahoe PK; Maheswaran S
    Cancer Res; 2007 Mar; 67(6):2747-56. PubMed ID: 17363596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
    Donato LJ; Suh JH; Noy N
    Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.
    Kwon YK; Jun JM; Shin SW; Cho JW; Suh SI
    Int J Oncol; 2005 Jun; 26(6):1597-603. PubMed ID: 15870875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib.
    Takahashi F; Chiba N; Tajima K; Hayashida T; Shimada T; Takahashi M; Moriyama H; Brachtel E; Edelman EJ; Ramaswamy S; Maheswaran S
    Oncogene; 2011 Jul; 30(27):3084-95. PubMed ID: 21339742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
    Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
    Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells].
    Wang HJ; Wu ZY; Fan P; Bian JM
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of B-cell translocation gene 2 protein in normal human tissues.
    Melamed J; Kernizan S; Walden PD
    Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific expression of B-cell translocation gene 2 (BTG2) and its function in T-cell immune responses in a transgenic mouse model.
    Terra R; Luo H; Qiao X; Wu J
    Int Immunol; 2008 Mar; 20(3):317-26. PubMed ID: 18195048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of BTG2 activity, a transcriptional target of p53: evidences and hypothesis].
    Puisieux A; Magaud JP
    Bull Cancer; 1999 Apr; 86(4):358-64. PubMed ID: 10341341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.
    Montanari M; Boninsegna A; Faraglia B; Coco C; Giordano A; Cittadini A; Sgambato A
    J Cell Physiol; 2005 Jan; 202(1):215-22. PubMed ID: 15389519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?
    Tirone F
    J Cell Physiol; 2001 May; 187(2):155-65. PubMed ID: 11267995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
    Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
    Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines.
    Lun M; Zhang PL; Siegelmann-Danieli N; Blasick TM; Brown RE
    Ann Clin Lab Sci; 2005; 35(1):15-24. PubMed ID: 15830705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.